GRAPPA 2024: Key Project Advances.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 40763940.
- Also identified by DOI 10.3899/jrheum.2025-0265.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Significant progress toward several key initiatives was presented during the Project Key Advances session of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting. Highlights included advancements from the Collaborative Research Network (CRN), with contributions from the Health Initiatives in Psoriasis and Psoriatic Arthritis Consortium European States (HIPPOCRATES) and developments in the complex-to-manage (C2M)/difficult-to-treat (D2T) psoriatic arthritis project. The presentation also included an update on the GRAPPA educational slide library. These activities underscore GRAPPA's continued dedication to fostering collaboration that advances psoriatic disease education and research toward improved patient outcomes.
Medical subject headings
- Psoriasis
- Arthritis, Psoriatic